N-Acetylmescaline

N-Acetylmescaline
Clinical data
Other namesNAM; Mescaline acetamide; N-Acetyl-3,4,5-trimethoxyphenethylamine
Identifiers
  • N-[2-(3,4,5-trimethoxyphenyl)ethyl]acetamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H19NO4
Molar mass253.298 g·mol−1
3D model (JSmol)
Melting point93 to 94 °C (199 to 201 °F)
  • O=C(NCCc1cc(OC)c(OC)c(OC)c1)C
  • InChI=1S/C13H19NO4/c1-9(15)14-6-5-10-7-11(16-2)13(18-4)12(8-10)17-3/h7-8H,5-6H2,1-4H3,(H,14,15)
  • Key:SNMFNOQKGANWHD-UHFFFAOYSA-N

N-Acetylmescaline, also known as mescaline acetamide or as N-acetyl-3,4,5-trimethoxyphenethylamine, is a mescaline derivative found in trace quantities in peyote (Lophophora williamsii). It is a minor metabolite of mescaline in humans, but has little pharmacological activity of its own. At doses of 306 to 756 mg orally, only mild drowsiness was observed at the highest dose. Hence, N-acetylmescaline appears to be inactive as a hallucinogen. N-Acetylmescaline has microtubule assembly inhibitory activity. The chemical synthesis of N-acetylmescaline has been described. N-Acetylmescaline was isolated and first synthesized by Ernst Späth and Johann Bruck and was described by them in the scientific literature in 1938.